Brokerages Set Amedisys, Inc. (NASDAQ:AMED) Price Target at $100.75
Shares of Amedisys, Inc. (NASDAQ:AMED – Get Free Report) have been assigned an average rating of “Hold” from the six ratings firms that are covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price […]
Shares of Amedisys, Inc. (NASDAQ:AMED – Get Free Report) have been assigned an average rating of “Hold” from the six ratings firms that are covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price […]
